China Biotech Services Holdings Limited (8037.HK)

HKD 0.49

(6.52%)

Revenue Summary of China Biotech Services Holdings Limited

  • China Biotech Services Holdings Limited's latest annual revenue in 2023 was 211.98 Million HKD , down -88.55% from previous year.
  • China Biotech Services Holdings Limited's latest quarterly revenue in 2024 Q2 was 16.22 Million HKD , down 0.0% from previous quarter.
  • China Biotech Services Holdings Limited reported a annual revenue of 1.85 Billion HKD in annual revenue 2022, up 196.83% from previous year.
  • China Biotech Services Holdings Limited reported a annual revenue of 623.76 Million HKD in annual revenue 2021, down -4.88% from previous year.
  • China Biotech Services Holdings Limited reported a quarterly revenue of 16.22 Million HKD for 2024 Q1, down -45.24% from previous quarter.
  • China Biotech Services Holdings Limited reported a quarterly revenue of 51.79 Million HKD for 2023 Q2, down -60.33% from previous quarter.

Annual Revenue Chart of China Biotech Services Holdings Limited (2023 - 2005)

Historical Annual Revenue of China Biotech Services Holdings Limited (2023 - 2005)

Year Revenue Revenue Growth
2023 211.98 Million HKD -88.55%
2022 1.85 Billion HKD 196.83%
2021 623.76 Million HKD -4.88%
2020 655.79 Million HKD 1007.49%
2019 59.21 Million HKD -15.77%
2018 70.3 Million HKD -33.13%
2017 105.13 Million HKD 21.45%
2016 86.56 Million HKD 153.66%
2015 34.12 Million HKD -75.69%
2014 140.38 Million HKD 64.58%
2013 85.3 Million HKD -15.84%
2012 101.35 Million HKD 125.15%
2011 45.01 Million HKD -46.53%
2010 84.18 Million HKD -47.56%
2009 160.52 Million HKD -41.04%
2008 272.27 Million HKD 0.56%
2007 270.75 Million HKD 11.24%
2006 243.38 Million HKD 23.26%
2005 197.45 Million HKD 0.0%

Peer Revenue Comparison of China Biotech Services Holdings Limited

Name Revenue Revenue Difference
Life Healthcare Group Limited 233.68 Million HKD 9.284%